stella
beta
Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis — Stella
Recruiting
Back to Parkinson Disease Psychosis trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
Johns Hopkins, Baltimore, Maryland
View full record on ClinicalTrials.gov